Featured News
Emory Ranked in the Top Ten Greenest Universities in the World!
Emory has been ranked among the top ten greenest universities in the world by Study International, and is one of the two U.S.-based institutions to feature on this list. The rankings recognize our commitment to sustainability in terms of reducing our environmental footprint, innovating green facilities such as the WaterHub which saves over 100 million gallons of water annually, and increasing sustainability awareness and programs for students, staff, faculty, and beyond.
This is a great motivator for us to keep working to meet our sustainability goals, including our Climate Action Planwhich was released last fall and our ongoing work on Emory's Sustainability Vision and Strategic Plan for 2025-2036!
Congratulations to these Bouchet Honors Society Inductees!
Congratulations to all the GDBBS students who were formally inducted into the Bouchet Honors Society on April 26, 2023:
- Veronica Canarte, Cancer Biology
- Yemko Pryor, Genetics & Molecular Biology
- Kedamawit Tilahun, Genetics & Molecular Biology
- Keenan Wiggins, Genetics & Molecular Biology
The National Edward Alexander Bouchet Graduate Honor Society is named for the first African American doctoral recipient in the United States, Dr. Edward Alexander Bouchet (Physics, Yale University, 1876). The Society honors outstanding scholarly achievement and promotes diversity and excellence in doctoral education and the professoriate.
Inductees at Emory are doctoral and postdoctoral scholars who are committed to contributing to the development of their field(s) of study and to the application of that knowledge into action to improve the lives and conditions of the community. Members exhibit the highest values of Emory University—through their integrity, honor, and exemplary conduct and behavior.
Emory ranked third in new drug discoveries by public institutions
Emory was recently ranked #3 in new analysis of new drug discoveries by public universities and research organizations, contributing more FDA-approved drugs and vaccines than any other public institution in the world except the University of California and the National Institutes of Health. The study, published in April in the Journal of Technology Transfer, analyzed international public-sector contributions to Food and Drug Administration-approved drugs and vaccines in search of a clearer understanding of worldwide biomedical innovation.
The authors, led by Ashley J. Stevens, PhD, founder of the intellectual property consultancy Focus IP Group LLC, consulted multiple sources to identify 364 FDA-approved drugs and vaccines from 1973 to 2016 that they categorized as discovered in whole or in part through public academic research. In order to be included, an institution needed to create specific intellectual property (IP) such as patented inventions or new materials needed to make, use or sell drugs and transfer its invention to a company, usually through a patent. Their analysis credited Emory researchers with 18 drugs in that period. Overall, public research institutions in the United States dominated academic drug discovery, with two thirds of the total approved by the FDA.
“In the context of the global public sector landscape, the U.S. dominates drug discovery,” the authors stated, “accounting for two-thirds of these drugs and many of the important, innovative vaccines introduced over the past 30 years.”
GDBBS Highlights, March 2023
